These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38966921)
1. [A Case of Metastatic Renal Cancer Responding to Sunitinib as the Eighth Line Therapy]. Yamazaki M; Sakai K; Kiyozuka K; Nakamura C; Kumagai M; Ueda M; Shiraishi Y; Imamura M; Yoshimura K Hinyokika Kiyo; 2024 May; 70(5):117-122. PubMed ID: 38966921 [TBL] [Abstract][Full Text] [Related]
2. [PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB]. Namura K; Otake S; Sawada T; Fujikawa A; Ota J; Moriyama M Nihon Hinyokika Gakkai Zasshi; 2015 Jan; 106(1):30-4. PubMed ID: 26399128 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of Sunitinib Rechallenge in Metastatic Renal Cell Carcinoma : A Case Report]. Yoshinaga A; Kamata S Hinyokika Kiyo; 2015 May; 61(5):201-5. PubMed ID: 26087822 [TBL] [Abstract][Full Text] [Related]
4. [Case of multiple lung metastases of renal cell carcinoma failing to respond to Interferon-alpha (IFN-alpha) and sunitinib but markedly responding to everolimus]. Nishikimi T; Tsuzuki T; Yamauchi Y; Yoshida S; Ishida R; Yamada H; Yokoi K; Kobayashi H Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):530-5. PubMed ID: 23819366 [TBL] [Abstract][Full Text] [Related]
5. Long-term stable disease in metastatic renal cell carcinoma: sorafenib sequenced to sunitinib and everolimus: a case study. Beck J; Bellmunt J; Escudier B Med Oncol; 2011 Dec; 28(4):1379-83. PubMed ID: 20593250 [TBL] [Abstract][Full Text] [Related]
6. [Brain metastasis which appeared during complete response of lung metastatic lesion by sunitinib treatment in a patient with renal cell carcinoma]. Morizawa Y; Momose H; Toyoshima Y; Takada S; Fujimoto K; Oyama N Hinyokika Kiyo; 2013 Dec; 59(12):791-3. PubMed ID: 24419011 [TBL] [Abstract][Full Text] [Related]
7. Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma. Santoni M; Conti A; Porta C; Procopio G; Sternberg CN; Basso U; De Giorgi U; Bracarda S; Rizzo M; Ortega C; Massari F; Iacovelli R; Derosa L; Masini C; Milella M; Di Lorenzo G; Atzori F; Pagano M; Buti S; De Vivo R; Mosca A; Rossi M; Paglino C; Verzoni E; Cerbone L; Muzzonigro G; Falconi M; Montironi R; Burattini L; Santini D; Cascinu S J Urol; 2015 Jan; 193(1):41-7. PubMed ID: 25046616 [TBL] [Abstract][Full Text] [Related]
8. Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma. Grünwald V; Lin X; Kalanovic D; Simantov R Eur Urol; 2016 Dec; 70(6):1006-1015. PubMed ID: 27238653 [TBL] [Abstract][Full Text] [Related]
9. Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib. Molina AM; Ginsberg MS; Motzer RJ Med Oncol; 2011 Dec; 28(4):1527-9. PubMed ID: 20697842 [TBL] [Abstract][Full Text] [Related]
10. Sunitinib-induced nephrotic syndrome in association with drug response in a patient with Xp11.2 translocation renal cell carcinoma. Liu YC; Chang PM; Liu CY; Yang CY; Chen MH; Pan CC; Chen MH Jpn J Clin Oncol; 2011 Nov; 41(11):1277-81. PubMed ID: 21965162 [TBL] [Abstract][Full Text] [Related]
11. Metastatic collecting duct carcinoma of the kidney treated with sunitinib. Tazi EM; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H World J Surg Oncol; 2011 Jul; 9():73. PubMed ID: 21752265 [TBL] [Abstract][Full Text] [Related]
12. Targeted Therapy for Renal Cell Carcinoma. Joshi R; Rawal S JNMA J Nepal Med Assoc; 2015; 53(198):83-8. PubMed ID: 26994026 [TBL] [Abstract][Full Text] [Related]
13. Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy. Calvo E; Schmidinger M; Heng DY; Grünwald V; Escudier B Cancer Treat Rev; 2016 Nov; 50():109-117. PubMed ID: 27664394 [TBL] [Abstract][Full Text] [Related]
14. [Metastasis to the Tongue from Renal Cell Carcinoma 10 Years after Nephrectomy : A Case Report]. Wang C; Takeda K; Shiba M; Takayama H; Munakata S Hinyokika Kiyo; 2016 Aug; 62(8):407-10. PubMed ID: 27624106 [TBL] [Abstract][Full Text] [Related]
15. Prolonged response to cytoreductive surgery and sunitinib in an elderly patient with synchronous multiple metastases from renal cell carcinoma. Locatelli MC; Miedico A; D'Antona A; Longo G; Maggioni M; Maggioni A; Tombolini P; Tabiadon D Tumori; 2010; 96(3):478-82. PubMed ID: 20845812 [TBL] [Abstract][Full Text] [Related]
17. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib. Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239 [TBL] [Abstract][Full Text] [Related]
18. Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients. Seidel C; Fenner M; Merseburger AS; Reuter C; Ivanyi P; Länger F; Ganser A; Grünwald V World J Urol; 2011 Jun; 29(3):355-60. PubMed ID: 21258806 [TBL] [Abstract][Full Text] [Related]
19. When tyrosine kinase inhibitor sunitinib can be discontinued in metastatic renal cell carcinoma to pancreas: a case report. Sbitti Y; Debbagh A; Slimani K; Mahi M; Errihani H; Ichou M J Med Case Rep; 2018 Mar; 12(1):80. PubMed ID: 29554941 [TBL] [Abstract][Full Text] [Related]
20. Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib. Zimmermann K; Schmittel A; Steiner U; Asemissen AM; Knoedler M; Thiel E; Miller K; Keilholz U Oncology; 2009; 76(5):350-4. PubMed ID: 19321976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]